UF News

AbFero Pharmaceuticals Announces Funding From Cure Parkinson’s for Lead Compound SP-420

AbFero Ltd., a subsidiary of UF startup AbFero Pharmaceuticals, Inc., a privately-held clinical stage pharmaceutical company dedicated to treating diseases of iron overload, announced the award of a grant from Cure Parkinson's for the development of their lead, brain-penetrant iron chelating agent, SP-420, as a disease modifying therapy for Parkinson's disease (PD).

Economic Impact

Despite the pandemic, University of Florida researchers conducted record amounts of research in 2020 and companies born of UF research continued to bring billions of dollars and thousands of jobs into the state.

UF Researcher Will Lead CureSearch for Children’s Cancer $1 Million Gift To Support Cutting-Edge Immunotherapy Trial for Pediatric High-Grade Glioma

CureSearch for Children’s Cancer has received a $1 million gift from the Norcross Family Foundation in support of a first-in-human, phase I/II clinical trial testing innovative personalized immunotherapy for pediatric high-grade gliomas, the primary cause of death in children with brain tumors. The project is funded through a CureSearch Catapult Award granted to pediatric oncologist Elias Sayour, MD, Ph.D. at the University of Florida.

Want our news in your inbox every Monday morning? You can!

Subscribe Here